Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma.

Journal: Cell

Published: 2019-10-03

DOI: 10.1016/j.cell.2019.08.052

Affiliations: 17

Authors: 27

Go to article
Institutions Share
MOE Key Laboratory of Carcinogenesis and Cancer Invasion, China 0.19
OrigiMed Co. Ltd., China 0.15
NIH NCI Office of Cancer Clinical Proteomics Research (OCCPR), United States of America (USA) 0.11
Department of Genetics and Genomic Sciences, ISMMS, United States of America (USA) 0.07
Department of Analytical Chemistry, SIMM CAS, China 0.06
CAS Key Laboratory of Receptor Research (CASKLRR), SIMM CAS, China 0.06
Department of Molecular and Human Genetics, BCM, United States of America (USA) 0.06
Lester and Sue Smith Breast Center, BCM, United States of America (USA) 0.06
University of Chinese Academy of Sciences (UCAS), China 0.05
State Key Laboratory of Epigenetics and Metabolism, Fudan University, China 0.04
CAS Center for Excellence in Molecular Cell Science, SIBS CAS, China 0.02
State Key Laboratory of Cell Biology (SKLCB), IBCB SIBS CAS, China 0.02
John T. Milliken Department of Medicine, WUSTL, United States of America (USA) 0.02
McDonnell Genome Institute (MGI), WUSTL, United States of America (USA) 0.02
Alvin J. Siteman Cancer Center, WUSTL, United States of America (USA) 0.02
Yale Department of Pharmacology, United States of America (USA) 0.02
Yale Cancer Biology Institute (YCBI), United States of America (USA) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER